The metabolic syndrome in Uygur and Kazak populations.

The metabolic syndrome, which has been defined as a clustering of insulin resistance, hypertension, and dyslipidemia (1–4), has become a major public health issue worldwide. Previous studies have shown that the prevalence of hypertension and diabetes was significantly different between the Uygur and Kazak populations, the two major minorities in Xinjiang (5,6). The current study aims to evaluate and compare the epidemiological and clinical features of the metabolic syndrome in the Uygur and Kazak ethnic populations.